Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 9475
This article has been cited by
1Comparison of 18F-Choline PET/CT and MRI functional parameters in prostate cancer
Xavier Palard-Novello,Luc Beuzit,Giulio Gambarota,Florence Le Jeune,Etienne Garin,Pierre-Yves Salaün,Anne Devillers,Solène Querellou,Patrick Bourguet,Hervé Saint-Jalmes
Annals of Nuclear Medicine.2019;33(1)47
[DOI]
2First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy
Franz Buchegger,Valentina Garibotto,Thomas Zilli,Laurent Allainmat,Sandra Jorcano,Hansjörg Vees,Olivier Rager,Charles Steiner,Habib Zaidi,Yann Seimbille,Osman Ratib,Raymond Miralbell
European Journal of Nuclear Medicine and Molecular Imaging.2014;41(1)68
[DOI]
3Impact of pelvic dynamic acquisition on final reading of 18 F-Fluorocholine positron emission tomography in patients with prostate adenocarcinoma: True need or unnecessary burden?
Adrien Latge,Céline Heimburger,Francois Severac,Nicolas Meyer,François Somme,Alessio Imperiale
Journal of Medical Imaging and Radiation Oncology.2022;66(3)324
[DOI]
4Impact of pelvic dynamic acquisition on final reading of 18 F-Fluorocholine positron emission tomography in patients with prostate adenocarcinoma: True need or unnecessary burden?
Mercy Akerele,Palak Wadhwa,Stefaan Vandenberghe,Charalampos Tsoumpas
Journal of Medical Imaging and Radiation Oncology.2017;66(3)1
[DOI]
5PET Angiography: Application of Early Dynamic PET/CT to the Evaluation of Arteries
Robert Drescher,Martin Freesmeyer
American Journal of Roentgenology.2013;201(4)908
[DOI]
6Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence
Jose R. Garcia,Gemma Cuberas,Eduard Riera,Marina Soler,Merce Moragas,Francisco Lomeña
Nuclear Medicine Communications.2015;36(1)8
[DOI]
7Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
Finn E. von Eyben,Kalevi Kairemo
Annals of Nuclear Medicine.2016;30(6)385
[DOI]
8A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis
Kalevi Kairemo,S. Cheenu Kappadath,Timo Joensuu,Homer A. Macapinlac
Diagnostics.2020;11(1)17
[DOI]
9Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
Julia Whitman,Isabel E. Allen,Emily K. Bergsland,Insoo Suh,Thomas A. Hope
Journal of Nuclear Medicine.2021;62(9)1285
[DOI]
10Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
Melvin E. Klegerman
Journal of Nuclear Medicine.2018;62(9)397
[DOI]
11Biologically-Based Mathematical Modeling of Tumor Vasculature and Angiogenesis via Time-Resolved Imaging Data
David A. Hormuth,Caleb M. Phillips,Chengyue Wu,Ernesto A. B. F. Lima,Guillermo Lorenzo,Prashant K. Jha,Angela M. Jarrett,J. Tinsley Oden,Thomas E. Yankeelov
Cancers.2021;13(12)3008
[DOI]
12Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?
Sotirios Chondrogiannis,Maria Cristina Marzola,Alice Ferretti,Gaia Grassetto,Anna Margherita Maffione,Lucia Rampin,Stefano Fanti,Francesco Giammarile,Domenico Rubello
European Journal of Nuclear Medicine and Molecular Imaging.2014;41(7)1293
[DOI]
13Standardization of acquisition protocols using PET/CT with 18F-Choline in prostate cancer
J.R. Garcia,M. Cozar,M. Soler,P. Bassa,E. Riera,M. Buxeda,E. Valls,J. Ferrer
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition).2020;39(4)204
[DOI]
14The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents
Dwaine Rieves,Paula Jacobs
Journal of Nuclear Medicine.2016;57(12)2022
[DOI]
15Impact and correction of the bladder uptake on18F-FCH PET quantification: a simulation study using the XCAT2 phantom
Jesús Silva-Rodríguez,Charalampos Tsoumpas,Inés Domínguez-Prado,Juan Pardo-Montero,Álvaro Ruibal,Pablo Aguiar
Physics in Medicine and Biology.2016;61(2)758
[DOI]
16[18F]Fluoromisonidazole PET in rectal cancer
Tanuj Puri,Tessa A. Greenhalgh,James M. Wilson,Jamie Franklin,Lia Mun Wang,Victoria Strauss,Chris Cunningham,Mike Partridge,Tim Maughan
EJNMMI Research.2017;7(1)758
[DOI]
17Estandarización de los protocolos de adquisición mediante PET/TC con 18F-Colina en el cáncer de próstata
J.R. Garcia,M. Cozar,M. Soler,P. Bassa,E. Riera,M. Buxeda,E. Valls,J. Ferrer
Revista Española de Medicina Nuclear e Imagen Molecular.2020;39(4)204
[DOI]
18Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT?
Daniele Di Biagio,Agostino Chiaravalloti,Mario Tavolozza,Paolo Abbatiello,Orazio Schillaci
Annals of Nuclear Medicine.2015;29(10)861
[DOI]
19New Acquisition Protocol of18F-Choline PET/CT in Prostate Cancer Patients: Review of the Literature about Methodology and Proposal of Standardization
Sotirios Chondrogiannis,Maria Cristina Marzola,Gaia Grassetto,Anna Margherita Maffione,Lucia Rampin,Emma Veronese,Arianna Massaro,Domenico Rubello
BioMed Research International.2014;2014(10)1
[DOI]
20Dual-phase 18F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan
Aaron Kian Ti Tong,Zoe Xiaozhu Zhang,Sumbul Zaheer,Xuexian Sean Yan
Clinical Imaging.2016;40(3)486
[DOI]
21Update on the use of radiopharmaceuticals for positron emission tomography imaging of prostate cancer
J.R. García
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition).2013;32(3)177
[DOI]
22Update on the use of radiopharmaceuticals for positron emission tomography imaging of prostate cancer
Tobias Franiel,Moritz Kasel-Seibert,Robert Drescher,Martin Freesmeyer
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition).2017;32(3)111
[DOI]
23Actualización del uso de radiofármacos en tomografía por emisión de positrones en el cáncer de próstata
J.R. García
Revista Española de Medicina Nuclear e Imagen Molecular.2013;32(3)177
[DOI]
24Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
Sotirios Chondrogiannis,Maria Cristina Marzola,Alice Ferretti,Anna Margherita Maffione,Lucia Rampin,Gaia Grassetto,Cristina Nanni,Patrick M. Colletti,Domenico Rubello
European Journal of Nuclear Medicine and Molecular Imaging.2013;40(9)1356
[DOI]
25Optimization of temporal sampling for 18F-choline uptake quantification in prostate cancer assessment
Xavier Palard-Novello,Anne-Lise Blin,Florence Le Jeune,Etienne Garin,Pierre-Yves Salaün,Anne Devillers,Giulio Gambarota,Solène Querellou,Patrick Bourguet,Hervé Saint-Jalmes
EJNMMI Research.2018;8(1)1356
[DOI]
26F-18 Choline PET angiography of the pelvic arteries: evaluation of image quality and comparison with contrast-enhanced CT
Martin Freesmeyer,Robert Drescher
Clinical Imaging.2015;39(3)437
[DOI]
27Radiotracer zur Diagnose des Prostatakarzinoms: Etablierte und neue Verfahren
Gábor Bakos,Mareike Roscher,Susana M. Granados,Martina Benešová
Der Nuklearmediziner.2020;43(04)275
[DOI]
28Optimized Protocol for 18F-Choline PET/CT in Patients with Biochemically Relapsed Prostate Cancer
Sotirios Chondrogiannis,Maria Cristina Marzola,Gaia Grassetto,Lucia Rampin,Arianna Massaro,Patrick M. Colletti,Domenico Rubello
Clinical Nuclear Medicine.2015;40(6)e308
[DOI]
Feedback
Subscribe

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal